These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36711070)

  • 21. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
    Danby SG; Andrew PV; Taylor RN; Kay LJ; Chittock J; Pinnock A; Ulhaq I; Fasth A; Carlander K; Holm T; Cork MJ
    Clin Exp Dermatol; 2022 Jun; 47(6):1154-1164. PubMed ID: 35167133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerance assessment of a new type of dermocosmetic in infants and children with moderate atopic dermatitis.
    Gayraud F; Sayag M; Jourdan E
    J Cosmet Dermatol; 2015 Jun; 14(2):107-12. PubMed ID: 25807867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of Quality of Life in Dialysis and Diabetic Patients by Skin Dryness and Pruritus Management with an Ecobiological Dermo-Cosmetic Product.
    Polena H; Chavagnac-Bonneville M; Sayag M
    Clin Cosmet Investig Dermatol; 2022; 15():2143-2152. PubMed ID: 36225393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-emollient liquid cleanser for very dry and atopic-prone skin: Results of an in-use tolerance and efficacy study conducted under dermatological, pediatric, and ophthalmological supervision.
    Favrel S; Mielewczyk E; Liberek A; Paw E; Chabowska I; Sirvent A; Ribet V; Delarue A
    J Cosmet Dermatol; 2020 May; 19(5):1155-1160. PubMed ID: 31773874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent studies of cutaneous nociception in atopic and non-atopic subjects.
    Heyer GR; Hornstein OP
    J Dermatol; 1999 Feb; 26(2):77-86. PubMed ID: 10091477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Tolerability of Steroid-Free, Over-the-Counter Treatment Formulations in Infants and Children With Atopic Dermatitis.
    Weber TM; Herndon JH; Ewer M; Stephens TJ; Flick I; Filbry A; Neufang G; Schoelermann AM
    J Dermatol Nurses Assoc; 2015 Jan; 7(1):17-24. PubMed ID: 25699134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periorbital dermatitis--a recalcitrant disease: causes and differential diagnoses.
    Feser A; Plaza T; Vogelgsang L; Mahler V
    Br J Dermatol; 2008 Sep; 159(4):858-63. PubMed ID: 18721191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy.
    Lüftner D; Dell'Acqua V; Selle F; Khalil A; Leonardi MC; De La Torre Tomás A; Shenouda G; Romero Fernandez J; Orecchia R; Moyal D; Seité S
    Onco Targets Ther; 2018; 11():5865-5872. PubMed ID: 30271169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Efficacy of an Ecobiological Dermo-Cosmetic Product to Help Manage and Prevent Relapses of Eyelid Atopic Dermatitis.
    Bergera-Virassamynaïk S; Ardiet N; Sayag M
    Clin Cosmet Investig Dermatol; 2023; 16():677-686. PubMed ID: 36969386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.
    Haque RM; Torkildsen GL; Brubaker K; Zink RC; Kowalski RP; Mah FS; Pflugfelder SC
    Cornea; 2010 Aug; 29(8):871-7. PubMed ID: 20508503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial Effects of Paraffin Bath Therapy as Additional Treatment of Chronic Hand Eczema: A Randomized, Single-Blind, Active-Controlled, Parallel-Group Study.
    Waked IS; Ibrahim ZM
    J Altern Complement Med; 2020 Dec; 26(12):1144-1150. PubMed ID: 33196289
    [No Abstract]   [Full Text] [Related]  

  • 34. Spectrum of periorbital dermatoses in South Indian population.
    Besra L; Jaisankar TJ; Thappa DM; Malathi M; Kumari R
    Indian J Dermatol Venereol Leprol; 2013; 79(3):399-407. PubMed ID: 23619445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay Thermal spring water as monotherapy or adjunctive therapy.
    Seite S; Benech F; Berdah S; Bayer M; Veyrat S; Segot E; Sakalikova M; Gibejova L; Zelenkova H
    J Drugs Dermatol; 2013 Aug; 12(8):920-4. PubMed ID: 23986166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tattoo aftercare management with a dermo-cosmetic product: Improvement in discomfort sensation and skin repair quality.
    Fauger A; Sonck S; Kluger N; Chavagnac-Bonneville M; Sayag M
    J Cosmet Dermatol; 2022 Mar; 21(3):1051-1056. PubMed ID: 33884740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
    Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.
    Weber TM; Samarin F; Babcock MJ; Filbry A; Rippke F
    J Drugs Dermatol; 2015 May; 14(5):478-85. PubMed ID: 25942666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
    Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
    Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.